Join the TechCrunch Disrupt SF Virtual Challenge

 
TechCrunch Disrupt

Heart failure is a chronic debilitating and potentially life-threatening disease affecting 26 million people worldwide. It is one of the most difficult and chronic heart diseases to manage and the biggest cause of hospital admissions in adults aged over 65 in the Western world (Source: Heart Failure). As a result, treatment costs, including hospitalizations, are estimated at $108 billion a year worldwide. About 25% of patients die within a year of diagnosis and 50% within five years (Source: CDC and WHO).

Calling all digital health entrepreneurs: Are you working on a disruptive cardiovascular solution? Our partners at Novartis are hosting a TechCrunch Disrupt SF virtual startup challenge with up to $30K in prizes! As a bonus (and to make your startup dreams come true), all finalists will receive passes to TechCrunch Disrupt SF.

Applicants are challenged to reimagine medicine by developing a digital tool that easily captures important cardiovascular vitals and monitors symptom progression, empowering patients to detect potential problems earlier and seek treatment sooner. If that sounds like you, apply today! Applications close on August 2.

Have you been working on a project but started before the hackathon began on June 5, 2018? The "Extended Innovation Challenge" will award a first prize of $12K.

What you get

First place includes $12K, a validation study (where appropriate), dedicated Novartis mentors, access to Novartis data lakes, free space and use of fabrication equipment, frequent encounters with industry leaders and investors through events, office hours, and networking opportunities.

- First place (Novartis Hackathon Challenge): $12,000 USD
- First place (Novartis Extended Innovation Challenge): $12,000 USD
- Second place: $8,000 USD
- Third place: $3,500 USD
- Fourth place: $2,500 USD
- Fifth place: $1,000 USD

All five finalists will receive passes to TechCrunch Disrupt SF and up to $500 of travel reimbursement.


NewsHITLABEvents